Transplantation

Article	Citations
COVID-19 and Solid Organ Transplantation: A Review Article	252
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant	144
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients	137
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept	105
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	104
Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research Network	100
Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India	79
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients	78
Guidelines for Perioperative Care for Liver Transplantation: Enhanced Recovery After Surgery (ERAS) Recommendations	74
Improved Organ Utilization and Better Transplant Outcomes With In Situ Normothermic Regional Perfusion in Controlled Donation After Circulatory Death	72
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection	72
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)	67
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis	67
How to Preserve Liver Grafts From Circulatory Death With Long Warm Ischemia? A Retrospective Italian Cohort Study With Normothermic Regional Perfusion and Hypothermic Oxygenated Perfusion	66
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration	64
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant	63
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response	61
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	61
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients	57
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic	55
Donor Warm Ischemia Time in DCD Liver Transplantation—Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference	53
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept	52
Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus Guidelines	52
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients	51
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients	50

Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation	50
Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience	49
The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients	48
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination	48
COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge	47
Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience	45
Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions	44
Dallas UtErus Transplant Study: Early Outcomes and Complications of Robot-assisted Hysterectomy for Living Uterus Donors	43
Global Estimates of Capacity for Kidney Transplantation in World Countries and Regions	42
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins	40
Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic	40
Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment	40
Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression	39
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies	39
Is it Safe to Be Transplanted From Living Donors Who Recovered From COVID-19? Experience of 31 Kidney Transplants in a Multicenter Cohort Study From India	38
Registry of the International Society of Uterus Transplantation: First Report	38
Fluid Management During Kidney Transplantation: A Consensus Statement of the Committee on Transplant Anesthesia of the American Society of Anesthesiologists	37
Normothermic Ex Vivo Kidney Perfusion for Human Kidney Transplantation: First North American Results	37
Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial	37
Liver Transplantation in Acute-on-chronic Liver Failure	37
Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates	36
Renal Normothermic Machine Perfusion: The Road Toward Clinical Implementation of a Promising Pretransplant Organ Assessment Tool	36
Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies	36
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference	35
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort	34
Breakthrough COVID-19 Infections After mRNA Vaccination in Solid Organ Transplant Recipients in Miami, Florida	33
Advances in Kidney Preservation Techniques and Their Application in Clinical Practice	32
The Full Spectrum of COVID-19 Development and Recovery Among Kidney Transplant Recipients	32
Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases	32
What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?	32
Pathways to Clinical Cardiac Xenotransplantation	30
The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression	30
Predicting Early Allograft Function After Normothermic Machine Perfusion	30
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review	30
Macrophages in Transplantation: A Matter of Plasticity, Polarization, and Diversity	29
The Role of SLAs in Xenotransplantation	29
Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation	28
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis	28
Regulations and Procurement Surgery in DCD Liver Transplantation: Expert Consensus Guidance From the International Liver Transplantation Society	28
Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients	28
Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: The Importance of a Washout Period	28
Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	28
Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States	27
Clamping of the Aortic Arch Vessels During Normothermic Regional Perfusion After Circulatory Death Prevents the Return of Brain Activity in a Porcine Model	27
Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers	27
Primary Nonfunction of the Liver Allograft	27
Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge	26
Solid Organ Transplantation in the Era of COVID-19: Lessons from France	26
Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study	26
Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society	26

Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis	26
The Molecular Phenotype of Kidney Transplants: Insights From the MMDx Project	26
Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation	25
Adenovirus Infection and Transplantation	25
Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein–specific T cells in Lung Transplant Recipients	25
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients	25
Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era	25
Normothermic Ex Situ Heart Perfusion With the Organ Care System for Cardiac Transplantation: A Meta-analysis	25
Current Status of ABO-incompatible Liver Transplantation	25
A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies	24
The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies	24
Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study	24
Uterine Transplantation: Review of Livebirths and Reproductive Implications	24
Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients	24
COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?	24
Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study	24
Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation	23
Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation	23
Major Thromboembolic Complications in Liver Transplantation: The Role of Rotational Thromboelastometry and Cryoprecipitate Transfusion	23
Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update	23
Understanding the Brain-based Determination of Death When Organ Recovery Is Performed With DCDD In Situ Normothermic Regional Perfusion	23
Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension	23
Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients: The Multicenter ADHERE BRAZIL Study	23
Is 0.6% Reasonable as the Minimum Requirement of the Graft-to-recipient Weight Ratio Regardless of Lobe Selection in Adult Living-donor Liver Transplantation?	23
Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation	22
Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis	22
Impact of Red Blood Cells on Function and Metabolism of Porcine Deceased Donor Kidneys During Normothermic Machine Perfusion	22
A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients	22
Emerging Concepts of Tissue-resident Memory T Cells in Transplantation	22
A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker	22
Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept	22
Age-dependent Sex Differences in Graft Loss After Kidney Transplantation	22
Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens	21
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford–AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India	21
Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA	21
Daratumumab for Antibody-mediated Rejection in Heart Transplant—A Novel Therapy: Successful Treatment of Antibody-mediated Rejection	21
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes	21
Lung Transplantation for Severe Post–coronavirus Disease 2019 Respiratory Failure	21
Ex Vivo Liver Splitting and Hypothermic Oxygenated Machine Perfusion: Technical Refinements of a Promising Preservation Strategy in Split Liver Transplantation	21
Complement Blockade in Recipients Prevents Delayed Graft Function and Delays Antibody-mediated Rejection in a Nonhuman Primate Model of Kidney Transplantation	20
New-onset Diabetes Mellitus After Adult Heart Transplantation and the Risk of Renal Dysfunction or Mortality	20
Incidence, Risk Factors, and Outcomes of COVID-19 Infection in a Large Cohort of Solid Organ Transplant Recipients	20
Long-term Outcomes After Facial Allotransplantation: Systematic Review of the Literature	20
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients	20
Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys	20
World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases	20
T-cell Exhaustion in Organ Transplantation	19
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium	19
Informed Consent for Potential Recipients of Pig Kidney Xenotransplantation in the United States	19
A Multicenter Cohort Study From India of 75 Kidney Transplants in Recipients Recovered After COVID-19	19
Heart Donation From Donors After Controlled Circulatory Death	19
Preliminary Clinical Experience of Molnupiravir to Prevent Progression of COVID-19 in Kidney Transplant Recipients	19
Impact of Belatacept Conversion on Renal Function, Histology, and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection	19
Mitochondrial Dysfunction and Oxidative Stress in Liver Transplantation and Underlying Diseases: New Insights and Therapeutics	19
Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients	18
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening	18
Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management	18
On the Way to Self-sufficiency: Improving Deceased Organ Donation in India	18
Prospective Clinical, Virologic, and Immunologic Assessment of COVID-19 in Transplant Recipients	18
Trends in COVID-19 Outcomes in Kidney Transplant Recipients During the Period of Omicron Variant Predominance	18
The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre– and Post–liver Transplant Outcomes	18
Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study	18
Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype	18
Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes	17
Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation	17
ECMO Long Haulers: A Distinct Phenotype of COVID-19–Associated ARDS With Implications for Lung Transplant Candidacy	17
A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis	17
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience	17
Validation of Cognitive Impairment in Combination With Physical Frailty as a Predictor of Mortality in Patients With Advanced Heart Failure Referred for Heart Transplantation	17
Kidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies	17
Liproxstatin-1 Alleviates Lung Transplantation-induced Cold Ischemia–Reperfusion Injury by Inhibiting Ferroptosis	17
Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury	17
Predicting Kidney Discard Using Machine Learning	17
Wages, Travel, and Lodging Reimbursement by the National Kidney Registry: An Important Step Toward Financial Neutrality for Living Kidney Donors in the United States	17
Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic	17
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry	16
Delivering siRNA Compounds During HOPE to Modulate Organ Function: A Proof-of-concept Study in a Rat Liver Transplant Model	16
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19	16
Outcomes of Nocardiosis and Treatment of Disseminated Infection in Solid Organ Transplant Recipients	16
The Higher COVID-19 Fatality Rate Among Kidney Transplant Recipients Calls for Further Action	16

Clinicopathological Analysis of Uterine Allografts Including Proposed Scoring of Ischemia Reperfusion Injury and T-cell–mediated Rejection—Dallas UtErus Transplant Study: A Pilot Study	16
Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!	16
Inactivated Whole-virus Vaccine Triggers Low Response Against SARS-CoV-2 Infection Among Renal Transplant Patients: Prospective Phase 4 Study Results	16
Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients	16
Infectious Complications in Tocilizumab-treated Kidney Transplant Recipients	16
Early Allograft Dysfunction and Complications in DCD Liver Transplantation: Expert Consensus Statements From the International Liver Transplantation Society	16
Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients	16
SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19	16
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients	15
Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention	15
Extracellular Vesicles Released During Normothermic Machine Perfusion Are Associated With Human Donor Kidney Characteristics	15
Meeting Report: First State of the Art Meeting on Gender Disparity in Kidney Transplantation in the Asia-Pacific	15
Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome	15
Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients	15
Monkeypox in Transplant Recipients: No Breaks Between Outbreaks	15
Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors	15
Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms	15
Histologic Antibody-mediated Kidney Allograft Rejection in the Absence of Donor-specific HLA Antibodies	15
Automated En Masse Machine Learning Model Generation Shows Comparable Performance as Classic Regression Models for Predicting Delayed Graft Function in Renal Allografts	15
Frailty Measures in Patients Listed for Lung Transplantation	15
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion	15
Psychosocial Evaluation of Candidates for Solid Organ Transplantation	15
Kidney Transplant and Dialysis Patients Remain at Increased Risk for Succumbing to COVID-19	14
Right Lobe Versus Left Lobe Living Donor Liver Transplantation: A Systematic Review and Meta-analysis of Donor and Recipient Outcomes	14
Outcomes Following Extrahepatic and Intraportal Pancreatic Islet Transplantation: A Comparative Cohort Study	14
Assessing the Relationship Between Molecular Rejection and Parenchymal Injury in Heart Transplant Biopsies	14
Updated Views on Neutrophil Responses in Ischemia–Reperfusion Injury	14
Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis	14
Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipien	14
Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients	14
A Comparison of Pulsatile Hypothermic and Normothermic Ex Vivo Machine Perfusion in a Porcine Kidney Model	14
The American Society of Transplant Surgeons Consensus Statement on Normothermic Regional Perfusion	14
Three-dimensional Vascularized β-cell Spheroid Tissue Derived From Human Induced Pluripotent Stem Cells for Subcutaneous Islet Transplantation in a Mouse Model of Type 1 Diabetes	14
Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers	14
The Fourth Dose of CoronaVac Vaccine Results in a Small Increase of Seroconversion and Antibody Values Among Kidney Transplant Recipients	14
Impact of Pretransplant and New-Onset Diabetes After Transplantation on the Risk of Major Adverse Cardiovascular Events in Kidney Transplant Recipients: A Population-based Cohort Study	14
Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients	14
Four Decades of Clinical Liver Transplantation Research: Results of a Comprehensive Bibliometric Analysis	14
The New 2021 CKD-EPI Equation Without Race in a European Cohort of Renal Transplanted Patients	14
Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study	14
A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell–mediated Inflammation	14
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?	14
Targeting T Follicular Helper Cells to Control Humoral Allogeneic Immunity	14
Treatment of Degenerative Disc Disease With Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results	14
Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation	14
How Did the Omicron Surge Affect Kidney Transplant Recipients Compared With a Cohort From the General Population?	13
N-acetylcysteine in the Donor, Recipient, or Both Donor and Recipient in Liver Transplantation: A Systematic Review With Meta-analysis and Trial Sequential Analysis	13
Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia-reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation	13
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults	13
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome	13
Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation	13
FOXP3 mRNA Profile Prognostic of Acute T Cell–mediated Rejection and Human Kidney Allograft Survival	13
Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation	13
Restoration of Bile Duct Injury of Donor Livers During Ex Situ Normothermic Machine Perfusion	13
DAMPs Released From Injured Renal Tubular Epithelial Cells Activate Innate Immune Signals in Healthy Renal Tubular Epithelial Cells	13
Infection, Rejection, and the Connection	13
Early Data on Utilization and Discard of Organs From COVID-19–infected Donors: A US National Registry Analysis	13
Desensitization in Crossmatch-positive Kidney Transplant Candidates	13
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors	13
Imlifidase-generated Single-cleaved IgG: Implications for Transplantation	13
Does Exercise Training Improve Physical Fitness and Health in Adult Liver Transplant Recipients? A Systematic Review and Meta-analysis	13
Treating Type 1 Diabetes by Pancreas Transplant Alone: A Cohort Study on Actual Long-term (10 Years) Efficacy and Safety	13
Liver Transplantation for Propionic Acidemia: Evidence From a Systematic Review and Meta-analysis	13
T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients	13
An Immune Atlas of T Cells in Transplant Rejection: Pathways and Therapeutic Opportunities	13
A Novel Technique for Bile Duct Division During Laparoscopic Living Donor Hepatectomy to Overcome Biliary Complications in Liver Transplantation Recipients: “Cut and Clip” Rather Than “Clip and Cut”	13
Challenging the Ex Vivo Lung Perfusion Procedure With Continuous Dialysis in a Pig Model	13
Alcohol-associated Liver Disease Is Now the Most Common Indication for Liver Transplant Waitlisting Among Young American Adults	13
Surfing the Big Data Wave: Omics Data Challenges in Transplantation	12
Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ	12
Prevention and Management of Donor-transmitted Cancer After Liver Transplantation: Guidelines From the ILTS-SETH Consensus Conference	12
A Novel Multidrug Combination Mitigates Rat Liver Steatosis Through Activating AMPK Pathway During Normothermic Machine Perfusion	12
Crossmatch, Donor-specific Antibody Testing, and Immunosuppression in Simultaneous Liver and Kidney Transplantation: A Review	12
India: Gender Disparities in Organ Donation and Transplantation	12
Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series	12
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?	12
Current and Potential Applications for Indocyanine Green in Liver Transplantation	12
Early Signs of Sinoatrial Reinnervation in the Transplanted Heart	12
High Prevalence of Long-COVID Among Kidney Transplant Recipients: A Longitudinal Cohort Study	12
Ensuring the Permanent Cessation of Brain Function During Normothermic Regional Perfusion	12
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Su	12
Clinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant Recipients	12
Utility of Banff Human Organ Transplant Gene Panel in Human Kidney Transplant Biopsies	12
Ex Vivo Normothermic Perfusion of Human Upper Limbs	12
Abdominal Organ Preservation Solutions in the Age of Machine Perfusion	12
The Molecular Diagnosis Might Be Clinically Useful in Discrepant Kidney Allograft Biopsy Findings: An Analysis of Clinical Outcomes	12
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients	12
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose	12
Immediate Postoperative Extubation Decreases Pulmonary Complications in Liver Transplant Patients	12
Disparities in Access to Kidney Transplantation in Developing Countries	12
Overcoming the Limits of Reconditioning: Seventeen Hours of EVLP With Successful Transplantation From Uncontrolled Circulatory Death Donor	11
Successful Liver Transplantation From a Deceased Donor With Vaccine-Induced Thrombotic Thrombocytopenia Causing Cerebral Venous Sinus and Hepatic Veins Thrombosis After ChAdOx1 nCov-19 Vaccination	11
Solid Organ Transplantation From Donors With COVID-19 Infection	11
Monoclonal Antibody Therapy for SARS-CoV-2 Infection in Kidney Transplant Recipients: A Case Series From Belgium	11
Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients	11